Sandra A. Brown, Ph.D.
Professor of Psychology and Psychiatry, University of California at San Diego
Chief of Psychology Service, Veterans Affairs San Diego Healthcare System
Associate Director of Child and Adolescent Services Research Center, Children's Hospital of San Diego

Sandra A. Brown, Ph.D. is Professor of Psychology and Psychiatry at the University of California, San Diego and Chief of Psychology Service at the Veterans Affairs San Diego Healthcare System.   She is also Associate Director of the Child and Adolescent Services Research Center at Children's Hospital of San Diego.   Dr. Brown is internationally recognized for her developmentally focused alcohol intervention research.   She is the past President of Division 50 (Addictions) of the American Psychological Association and has over 190 publications.    She is involved in addiction prevention and intervention at the regional, state and national level.   Dr. Brown's NIAAA funded research yielded some of the pioneering information on the relapse process for youth as well as long term outcomes for clinical samples of youth with alcohol and drug problems.    Her current research investigates processes whereby youth escalate or diminish their alcohol use with and without treatment, and the role of psychiatric comorbidity in alcohol and drug abuse treatment.

Vivian H. Brown, Ph.D.
CEO and Founder, PROTOTYPES Centers for Innovation in Health, Mental Health and Social Services

Presentation:
Women's Substance Abuse Treatment

Dr. Vivian B. Brown is President and Chief Executive Officer of PROTOTYPES, Centers for Innovation in Health, Mental Health and Social Services.    She founded this nonprofit organization in 1986, based on an identified need for services that would be flexible enough to meet the demands of rapidly changing communities.   Under her guidance, PROTOTYPES provides substance abuse treatment and prevention programs to women and their children; HIV/AIDS outreach education, prevention, and community services to women and their families; mental health treatment and dual diagnosis interventions; trauma interventions and preventions; and training, technical assistance, consultation, and research.   Dr. Brown has served as a consultant in the areas of health, substance abuse and mental health to a wide variety of national and international organizations.   She currently holds the position of Associate Professor for the Department of Psychiatry at University of California Los Angeles.

Michael Gitlin, M.D.
Professor of Clinical Psychiatry, UCLA School of Medicine
Director of the Adult Division in the Department of Psychiatry
Director of the Mood Disorders Clinic at the UCLA Neuropsychiatric Hospital
and Medical Director of the Aftercare Clinic

Presentation:
Psychopharmacology for Substance Abuse and Mental Health Clinicians

Michael J. Gitlin, M.D. is Professor of Clinical Psychiatry at the UCLA School of Medicine.   He is currently the Director of the Adult Division in the Department of Psychiatry and Director of the Mood Disorders Clinic at the UCLA Neuropsychiatric Hospital, where he is also the Medical Director of the Aftercare Clinic, a research clinic in schizophrenia.   He is the author of many scientific articles and book chapters as well as two editions of a solo authored psychopharmacology textbook written for nonphysician therapists entitled "The Psychotherapist's Guide to Psychopharmacology” published by the Free Press.   He served as Chief of Staff at the Neuropsychiatric Hospital from 1997-1999.   His most recent award was:  Distinguished Educator Award in Teaching from the UCLA Department of Psychiatry, the UCLA Department of Psychiatry.

Walter Ling, M.D.
Professor of Psychiatry and Director, Integrated Substance Abuse Programs
Department of Psychiatry and Biobehavioral Sciences
David Geffen School of Medicine
University of California, Los Angeles

Presentation:
Prescription Drug Abuse

Dr. Walter Ling is a board-certified neurologist and psychiatrist, licensed to practice in the state of California.   He is active in both research and clinical work, having been listed in the ‘Best Doctors of America’, ‘Best Doctors in the West’, and ‘Best Doctors in Los Angeles’.   He was also named by ‘Good Housekeeping’ magazine as one of the 327 best mental health clinicians in the US.   Dr. Ling is Professor of Psychiatry and Director of the Integrated Substance Abuse Programs (ISAP) at UCLA.   His work in opiate pharmacotherapy has provided pivotal information for the approval of LAAM, naltrexone, and buprenorphine.   In addition, his group conducts a wide range of epidemiological and treatment service outcome research in California and throughout the US.   He is a consultant for numerous private and public agencies, both locally, nationally and internationally.    These agencies include the National Institute on Drug Abuse, the US Department of State, the UN Office of International Narcotics Affairs and the World Health Organization.

Edythe D. London, Ph.D.
Professor of Psychiatry and Biobehavioral Sciences,
Professor of Molecular and Medical Pharmacology
University of California Los Angeles

Presentation:
Methamphetamine and the Brain

Dr. London is Professor of Psychiatry and Pharmacology at the David Geffen School of Medicine at UCLA.   She came to UCLA after a long career at the National Institute on Drug Abuse, where she started the Neuroscience Research Branch and built and directed the Brain Imaging Center.   Dr. London’s primary research contributions are in the application of brain imaging methods to the study of substance abuse.   She has trained a number of successful researchers, and has authored 233 original research articles and 68 reviews, most of them basic science papers on drug action in the brain.   Her current research focuses on nicotine and methamphetamine dependence and the problem of impulse control.

G. Alan Marlatt, Ph.D.
Professor and Director, Addictive Behaviors Research Center
Department of Psychology, University of Washington

Presentation:
Mindfulness in Substance Abuse Treatment

G. Alan Marlatt is Professor of Psychology and Director of the Addictive Behaviors Research Center at the University of Washington.   His major focus in both research and clinical work is the field of addictive behaviors.   In addition to over 200 journal articles and book chapters, he has published several books in the addictions field, including Relapse Prevention (1985), Assessment of Addictive Behaviors (1988), Harm Reduction (1998), and Brief Alcohol Screening and Intervention for College Students (BASICS):   A Harm Reduction Approach (1999).   In 1990, Dr. Marlatt was awarded the Jellinek Memorial Award for outstanding contributions to knowledge in the field of alcohol studies, in 2001 he was given the Innovators in Combating Substance Abuse Award by the Robert Wood Johnson Foundation, and in 2004 he received the Distinguished Research Award from the Research Society on Alcoholism.

Richard A. Rawson, Ph.D.
Associate Director, Integrated Substance Abuse Programs (ISAP)
Neuropsychiatric Institute and Hospital
University of California, Los Angeles

Presentation:
Latest Research on Methamphetamine Abuse and Treatment

Dr. Rawson received a PhD in experimental psychology from the University of Vermont in 1974.   Since that time he has spent his career conducting research and developing treatment systems for substance abuse disorders.   Dr. Rawson has been a member of the UCLA Department of Psychiatry for over 20 years.   In his role as ISAP Associate Director, Dr. Rawson oversees a portfolio of addiction research ranging from brain imaging studies to numerous clinical trials on pharmacological and psychosocial addiction treatments to the study of how new treatments are applied in the treatment system.   During the past decade, he has worked with the U.S. State Department on large substance abuse research and treatment projects, exporting technology and addiction science to Mexico, Thailand, Israel, Egypt, and the Palestinian Authority.   Dr. Rawson has published two books, 15 book chapters, and over 125 professional papers and has conducted over 1,000 workshops, paper presentations, and training sessions.

Arnold Washton, Ph.D.
Executive Director, Recovery Options

Presentation:
Addiction Treatment in Private Practice

Arnold M. Washton, Ph.D., a licensed psychologist specializing in addiction treatment since 1975.   He is Executive Director of Recovery Options, a private practice of addiction psychology located in New York City and Princeton, NJ.   A noted clinician, researcher, and author of over 100 professional publications including several books, his work in recent years has focused on strategies for treating alcohol and drug problems in office-based practice, as described in his forthcoming book from Guilford Press (coauthored with Joan Zweben, Ph.D.), “Treating Alcohol and Drug Problems in Psychotherapy Practice:   Doing What Works".

• Sex Addiction and Other Compulsive Disorders

• Domestic Violence
  (Licensure course MFTs, LCSWs, and Psychologists)

• Medications for Addiction Treatment: Buprenorphine

Emilio I. Mendoza
L.A. County Dept. of Children & Family Services

• Meth Labs and Drug Endangered Children

Jeanne L. Obert, M.F.T., M.S.M.
Matrix Institute on Addictions

Richard Rawson, PhD
University of California, Los Angeles

• Methamphetamine Treatment Skills

Elke Rechberger, Ph.D.
PROTOTYPES

Vivian H. Brown, Ph.D.
PROTOTYPES Centers for Innovation in Health, Mental Health and Social Services

• Evidence-Based Treatment for Trauma, PTSD and Addiction

• Using Mindfulness in Subance Abuse Treatment

• Medications for Addiction Treatment

• Update Adolescent Treatment Strategies

Panel Moderators:

Thomas E. Freese, Ph.D.
UCLA Integrated Substance Abuse Programs

Michael Shafer, Ph.D.
University of Arizona

• Developing New Leaders in the Field of Substance Abuse Treatment